1. Home
  2. NEO
  3. NEO News

Latest NeoGenomics Inc. (NEO) News on May 9, 2025

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares
NEO

Simply Wall St.

7 hours ago

Chief Financial Officer of NeoGenomics Jeffrey Sherman Buys 14% More Shares

NEO

Argus Research

3 days ago

NEO: Raising target price to $6.00

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
NEO

Simply Wall St.

4 days ago

NeoGenomics First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Small-Cap Stocks Walking a Fine Line
NEO

StockStory

5 days ago

3 Small-Cap Stocks Walking a Fine Line

NEO

MT Newswires

8 days ago

NeoGenomics Repays $201.3 Million Convertible Senior Notes

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley
NEO

TipRanks

8 days ago

NeoGenomics price target lowered to $10 from $17 at Morgan Stanley

NeoGenomics Pays Off 1.25% Convertible Senior Notes
NEO

Business Wire

8 days ago

NeoGenomics Pays Off 1.25% Convertible Senior Notes

NEO

MT Newswires

9 days ago

Leerink Partners Downgrades NeoGenomics to Market Perform From Outperform, Lowers Price Target to $9 From $25

NEO

GuruFocus.com

9 days ago

NeoGenomics Inc (NEO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Why NeoGenomics (NEO) Stock Is Nosediving
NEO

StockStory

10 days ago

Why NeoGenomics (NEO) Stock Is Nosediving

NEO

MT Newswires

10 days ago

Needham Cuts NeoGenomics' Price Target to $8.50 From $18, Maintains Buy Rating

NEO

MT Newswires

10 days ago

NeoGenomics Expands Cancer Test Offerings With Ultima Genomics Collaboration

NEO

MT Newswires

10 days ago

NeoGenomics Posts Q1 Breakeven Adjusted Earnings as Revenue Rises; 2025 Guidance Updated

NeoGenomics (NEO) Reports Break-Even Earnings for Q1
NEO

Zacks

10 days ago

NeoGenomics (NEO) Reports Break-Even Earnings for Q1

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
NEO

PR Newswire

10 days ago

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops
NEO

StockStory

10 days ago

NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock Drops

NEO

Associated Press Finance

10 days ago

NeoGenomics: Q1 Earnings Snapshot

NeoGenomics Reports First Quarter 2025 Results
NEO

Business Wire

10 days ago

NeoGenomics Reports First Quarter 2025 Results

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For
NEO

StockStory

11 days ago

NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
NEO

Zacks

16 days ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
NEO

Zacks

17 days ago

NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
NEO

Business Wire

17 days ago

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

NEO

Argus Research

24 days ago

NEO: Rating decreased to a SELL

NEO

MT Newswires

25 days ago

BofA Securities Adjusts Price Target on NeoGenomics to $12 From $16, Maintains Neutral Rating

NEO

Argus Research

a month ago

NEO: Lowering target price to $9.00

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
NEO

Business Wire

a month ago

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

NEO

MT Newswires

a month ago

NeoGenomics Closes Pathline Acquisition

NeoGenomics Completes Acquisition of Pathline
NEO

Business Wire

a month ago

NeoGenomics Completes Acquisition of Pathline

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
NEO

StockStory

a month ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)

NEO

Argus Research

a month ago

NEO: What does Argus have to say about NEO?

NEO

MT Newswires

a month ago

NeoGenomics Appoints Tony Zook Chief Executive

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics
NEO

Business Wire

a month ago

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack
NEO

StockStory

a month ago

A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses
NEO

StockStory

a month ago

Q4 Testing & Diagnostics Services Earnings: RadNet (NASDAQ:RDNT) Impresses

3 Reasons to Sell NEO and 1 Stock to Buy Instead
NEO

StockStory

2 months ago

3 Reasons to Sell NEO and 1 Stock to Buy Instead

NEO

MT Newswires

2 months ago

NeoGenomics Names Warren Stone President, COO

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer
NEO

Business Wire

2 months ago

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)
NEO

StockStory

2 months ago

Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking Quest (NYSE:DGX)

3 Small-Cap Stocks in Hot Water
NEO

StockStory

2 months ago

3 Small-Cap Stocks in Hot Water

NEO

MT Newswires

2 months ago

NeoGenomics Acquires Pathline

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
NEO

Business Wire

2 months ago

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

NEO

Argus Research

2 months ago

NEO: Lowering target price to $10.00

3 Healthcare Stocks Skating on Thin Ice
NEO

StockStory

2 months ago

3 Healthcare Stocks Skating on Thin Ice

NEO

Argus Research

2 months ago

NEO: Lowering target price to $11.00

NeoGenomics to Participate in Upcoming Investor Conferences
NEO

Business Wire

3 months ago

NeoGenomics to Participate in Upcoming Investor Conferences

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations
NEO

Simply Wall St.

3 months ago

NeoGenomics Full Year 2024 Earnings: EPS Beats Expectations

NEO

GuruFocus.com

3 months ago

NeoGenomics Inc (NEO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

NEO

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Neogenomics Inc Earnings Call

NEO

Argus Research

3 months ago

NEO: Lowering target price to $13.00

Why NeoGenomics (NEO) Shares Are Trading Lower Today
NEO

StockStory

3 months ago

Why NeoGenomics (NEO) Shares Are Trading Lower Today

NeoGenomics (NEO) Tops Q4 Earnings Estimates
NEO

Zacks

3 months ago

NeoGenomics (NEO) Tops Q4 Earnings Estimates

NEO

MT Newswires

3 months ago

NeoGenomics Q4 Adjusted Earnings, Revenue Rise; 2025 Guidance Issued -- Shares Drop Pre-Bell

NEO

Associated Press Finance

3 months ago

NeoGenomics: Q4 Earnings Snapshot

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets
NEO

StockStory

3 months ago

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
NEO

Business Wire

3 months ago

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect
NEO

StockStory

3 months ago

NeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To Expect

NEO

Thomson Reuters StreetEvents

3 months ago

Q4 2024 Adaptive Biotechnologies Corp Earnings Call

NEO

Argus Research

3 months ago

NEO: Lowering target price to $15.00

NEO

MT Newswires

3 months ago

Pacific Biosciences of California Appoints NeoGenomics CEO to Board of Directors

PacBio Announces Appointment of Chris Smith to Board of Directors
NEO

GlobeNewswire

3 months ago

PacBio Announces Appointment of Chris Smith to Board of Directors

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
NEO

Business Wire

3 months ago

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

NEO

Argus Research

3 months ago

NEO: Raising target price to $16.00

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss
NEO

Simply Wall St.

3 months ago

Strong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year loss

NEO

Argus Research

4 months ago

NEO: Raising target price to $15.00

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance
NEO

Investor's Business Daily

4 months ago

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance

NEO

MT Newswires

4 months ago

NeoGenomics Provides 2025 Revenue Outlook

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
NEO

Business Wire

4 months ago

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?
NEO

Zacks

4 months ago

NeoGenomics (NEO) Surges 9.1%: Is This an Indication of Further Gains?

NEO

Argus Research

4 months ago

NEO: Lowering target price to $14.00

NEO

MT Newswires

4 months ago

Adaptive Biotechnologies, NeoGenomics to Support Minimal Residual Disease Monitoring Options for Blood Cancer Patients

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients
NEO

GlobeNewswire

4 months ago

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

NEO

MT Newswires

4 months ago

Benchmark Downgrades NeoGenomics to Hold From Buy

NEO

MT Newswires

4 months ago

NeoGenomics Appoints Tony Zook as CEO

NeoGenomics Announces Chief Executive Officer Succession
NEO

Business Wire

4 months ago

NeoGenomics Announces Chief Executive Officer Succession

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
NEO

Business Wire

4 months ago

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

NeoGenomics (NEO) Upgraded to Buy: Here's Why
NEO

Zacks

4 months ago

NeoGenomics (NEO) Upgraded to Buy: Here's Why

NEO

Argus Research

5 months ago

NEO: Lowering target price to $17.00

NEO

Argus Research

5 months ago

NEO: Rating increased to a HOLD

NEO

MT Newswires

5 months ago

Natera Expands Lawsuit Against NeoGenomics to Include Additional Patent

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma
NEO

Business Wire

5 months ago

NeoGenomics’ Newly Published Study Underscores Potential of ctDNA as a Predictive Tool for Monitoring Patients with High-Risk Melanoma

NEO

Argus Research

5 months ago

NEO: Raising target price to $17.00

NEO

MT Newswires

5 months ago

Jefferies Initiates NeoGenomics at Buy With $22 Price Target

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting
NEO

Business Wire

5 months ago

NeoGenomics to Present Key Research on Hematologic Malignancies at the 2024 American Society of Hematology Annual Meeting

NEO

Argus Research

5 months ago

NEO: Raising target price to $16.00

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
NEO

Business Wire

6 months ago

NeoGenomics to Present New Data at AMP 2024, Highlighting the Impact of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Felicia Williams Joins NeoGenomics Board of Directors
NEO

Business Wire

6 months ago

Felicia Williams Joins NeoGenomics Board of Directors

NEO

Argus Research

6 months ago

NEO: Raising target price to $17.00

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
NEO

Business Wire

6 months ago

NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know
NEO

Zacks

6 months ago

NeoGenomics (NEO) Upgraded to Strong Buy: Here's What You Should Know

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations
NEO

Simply Wall St.

6 months ago

NeoGenomics Third Quarter 2024 Earnings: EPS Beats Expectations

NEO

Thomson Reuters StreetEvents

6 months ago

Q3 2024 Neogenomics Inc Earnings Call

NEO

GuruFocus.com

6 months ago

NeoGenomics Inc (NEO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...

NEO

Argus Research

6 months ago

NEO: Raising target price to $16.00

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say
NEO

Zacks

6 months ago

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say

NEO

MT Newswires

6 months ago

NeoGenomics' Q3 Adjusted Earnings, Revenue Rise

NEO

Associated Press Finance

6 months ago

NeoGenomics: Q3 Earnings Snapshot

NeoGenomics Reports Third Quarter 2024 Results
NEO

Business Wire

6 months ago

NeoGenomics Reports Third Quarter 2024 Results

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade
NEO

Zacks

6 months ago

Wall Street Analysts Believe NeoGenomics (NEO) Could Rally 51.29%: Here's is How to Trade

NeoGenomics gains conditional approval for solid tumour assays in New York
NEO

Medical Device Network

7 months ago

NeoGenomics gains conditional approval for solid tumour assays in New York

NEO

MT Newswires

7 months ago

NeoGenomics Gets Conditional Approval for Cancer Tests in New York

Share on Social Networks: